England expands pharmacy treatments to 12 conditions including migraines and acne

England's pharmacies are about to take on five new conditions this autumn, expanding what chemists can treat without forcing patients through their GP first. Migraines, acne, ear infections, scabies, and severely blocked noses will join seven conditions already handled at the counter—sore throats, earache, sinusitis, shingles, impetigo, infected bites, and urinary tract infections. The move is part of the Pharmacy First scheme, which launched in 2024 and has already delivered 14 million consultations, including two million for sore throats and 1.7 million for UTIs.

The expansion comes as the NHS faces mounting pressure. England's A&E departments recorded three of their busiest months on record after an exceptionally hot summer, and officials say the system needs relief. By routing common, manageable conditions away from GP surgeries and emergency departments, the NHS hopes to free up capacity for more serious cases while giving patients faster access to treatment. Prime Minister Andy Burnham framed it as giving people back control of their time—no scrambling for routine appointments, no taking time off work, no waiting weeks to be seen. "For five more common conditions, you'll be able to walk into your local pharmacy and get treated on the spot," he said.

The rollout will be gradual. A few hundred chemists will initially offer treatment for the five new conditions, with the service eventually expanding to thousands of community NHS pharmacies across England. People can access it three ways: by being referred through NHS111, by their GP, or simply by walking into their local high street chemist. The Migraine Trust, which has long advocated for better pharmacy-based migraine support, called the news a breakthrough. Chief executive Rob Music described it as "a wonderful opportunity for a faster and improved care pathway" for people living with migraines.

Dr Amanda Doyle, NHS England's director for primary care and community services, emphasized the goal of keeping patients out of hospitals unnecessarily by providing community-based support. Community pharmacies already offer a range of services beyond dispensing—healthy eating advice, exercise support, smoking cessation help, blood pressure monitoring, contraception, and flu and Covid vaccinations. The new conditions represent another layer in what the NHS is positioning as a more distributed model of primary care.

But the expansion has exposed a persistent tension. Pharmacy bodies across England have repeatedly warned that government funding does not match the workload these schemes demand. Henry Gregg, chief executive of the National Pharmacy Association, acknowledged the expansion while pushing back on resources. "Pharmacies are still under significant financial pressures," he said. "This shows why the government should go much further and invest in our pharmacy network that has the power to transform people's experience of everyday health issues." The complaint reflects a broader pattern: the NHS is asking community pharmacies to absorb more clinical work, but the money allocated to support that work has not kept pace.

England is not pioneering this model. Scotland launched a similar scheme that became the template for Pharmacy First, and Scottish pharmacies now treat 27 different conditions. Northern Ireland and Wales have their own systems allowing pharmacies to handle certain conditions directly. The fact that Scotland's network handles nearly double the number of conditions suggests there is room for further expansion in England—if funding follows.